Microlose is a pharmaceutical co processed excipient composed of Microcrystalline Cellulose and Lactose Monohydrate. Microlose is specifically engineered to deliver consistent performance in oral solid dosage forms (OSD), particularly those manufactured using direct compression.

Microlose excipient improves flowability, compressibility, and uniformity in oral dosage forms.

Microlose offers excellent compressibility and good powder flow, with a balanced compaction profile that results in tablets with high hardness, low friability, and reliable disintegration, making it well suited for immediate release oral solid dosage forms.

The Microlose coprocessed excipient can also support modified release profiles. Lactose Monohydrate excipient promotes rapid dissolution for immediate release, while the Microcrystalline Cellulose excipient contributes to matrix formation for sustained drug release. This combination of the two pharmaceutical excipients allows flexible control over release behavior within a single excipient system.

The Microlose coprocessed excipient is suitable for a wide range of pharmaceutical oral solid dosage forms (OSD), including immediate-release tablets, chewable tablets, capsules, and nutraceutical formulations.

This pharmaceutical excipient performs well in both low-dose and high-dose oral dosage forms where content uniformity is critical.

The Microlose co-processed excipient from Gangwal Healthcare is manufactured under stringent GMP conditions to ensure consistent quality, reliability, and regulatory compliance.

Backed by Gangwal Healthcare’s expertise in pharmaceutical excipients, Microlose supports efficient pharmaceutical manufacturing and dependable formulation performance.